Recent Recalls and Warnings About Dangerous Pharmaceutical Drugs

As of the end of April 2013, the FDA had already announced 17 recalls of dangerous pharmaceutical drugs in 2013. This article summarizes a few of the 2013 dangerous drug recalls. You can review all dangerous drug recalls on the FDA’s website.

Hospira, 0.9% Sodium Chloride Injection

On March 29, 2013, Hospira issued a voluntary recall of one lot of sodium chloride injection after a consumer reported the presence of brass particulate in the container. The sodium chloride injection is packaged in a 1000 mL flexible container, lot number 25-037-JT (the lot number may be followed by a -01 or -90), with an expiration date of January 1, 2015. The recalled lot was distributed nationwide between January 2013 and March 2013. Read more about the Hospira sodium chloride injection recall on the FDA’s website.

Clinical Specialties, Avastin Unit Dose Syringes

On March 18, 2013, Clinical Specialties issued a nationwide recall of these unit dose syringes after receiving five reports of intra-ocular eye infections in patients on whom these syringes were used. The product was administered by a licensed physician in a surgery or physician’s office setting. The syringes were distributed to doctors’ offices in Georgia, Louisiana, South Carolina, and Indiana from December 18, 2012 to present. Read more about the Clinical Specialties Avastin recall on the FDA’s website.

Advance Pharmaceutical, 325 mg Ferrous Sulfate Tablets

On January 17, 2013, Advance Pharmaceutical recalled one lot of 325 mg ferrous sulfate tablets that were found to actually contain Meclizine HCl 25 mg tablets. The ferrous sulfate tablets were packaged in 100-count bottles under the label “Rugby NATURAL IRON SUPPLEMENT Ferrous Sulfate.” Taking Meclizine HCI 25 mg in the dosages recommended on the bottles labeled as ferrous sulfate 325 mg can cause serious health effects in people who drink alcohol or take sedatives, have a pre-existing central nervous system condition, have impaired kidneys or livers, in the elderly, and in nursing and newborn infants whose mothers ingested the drug. The serious side effects include Meclizine toxicity, which may lead to the following potentially life-threatening, serious, adverse events:

  • impaired alertness,
  • confusion,
  • drowsiness,
  • coma,
  • low blood pressure,
  • and respiratory depression.

Read more about Advance Pharmaceutical’s ferrous sulfate recall on the FDA’s website.

Contact Attorney Kevin Buchanan for Answers to Questions About Dangerous or Defective Pharmaceutical Drugs

Kevin Buchanan is a Dallas lawyer offering personal injury clients skillful and experienced representation with a strong emphasis on fairness, and on treating all clients with dignity and respect. If you have questions about serious adverse health effects caused by a dangerous pharmaceutical drug, Mr. Buchanan would be pleased to review your circumstances and offer his opinion. To schedule a private consultation, fill out the online intake form or call (214) 378-9500.


About the Firm

Kevin Buchanan & Associates, P.L.L.C., are a Dallas based civil litigation firm that handles a variety of cases, including personal injury, product liability, and business disputes in many jurisdictions throughout the United States.

Our firm recently negotiated a $1.25 million dollar settlement for the family of a man who died as a result of a head-on collision with a wrong-way driver.

Latest Tweets

Get in Touch

2030 Main Street
Suite 700
Dallas, Texas 75201
(214) 378-9500